DAFTAR PUSTAKA Diakses dari : Hormon Therapy. In Clinical Gynecologic Endocrinology and

(1)

DAFTAR PUSTAKA

1.

Data dan Informasi Kinerja Pembangunan Republik Indonesia 2004 – 2012. Diakses dari : http://www.bappenas.go.id

2.

MenKes R.I. 2008 Keputusan Menteri Kesehatan Republik Indonesia nomor 1142/Menkes/SK/XII/2008 tentang Pedoman Pengendalian Osteoporosis

3.

Klein NA, Soules MR. Endocrine changes of the menopause. Clin Obstet Gynecol 2004;41:912-20,

4.

Nochtigall LE. The symptoms of perimenopause. Clin Obstet Gynecol 2004;41:921-27,

5.

Speroff L, Osteoporosis and Menopause and Postmenopausal Hormon Therapy. In Clinical Gynecologic Endocrinology and Infertility, 8th.ed, Williams & Wilkins, USA, 2011, 583-650 Speroff L, Osteoporosis and Menopause and Postmenopausal Hormon Therapy. In Clinical Gynecologic Endocrinology and Infertility, 8th.ed, Williams & Wilkins, USA, 2011, 583-650

6.

Lukanova A, Lundin E, Zelenuich-Jacquotte A, Muti P, Murel A, Rinaldi S, et al. 2004 Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women, European Journal of Endocrinology; 150: 161-171

7.

Baziad A. 2003 Endokrinologi Ginekologi. Edisi Kedua. Media Aesculapius. Fakultas Kedokteran Universitas Indonesia. 82-84

(2)

8.

Hurd WW. Menopause In : Berek JS (ed) Novak‟s Gynekology. Twelfth Edition The william and Wilkins Company,Baltimore, 2010; 29: 981-1011

9.

World Health Organization, 1996. Assesment of Fracture Risk and Its Aplication to Skreening for Post Menopausal Osteoporosis. WHO Technical Reports Series;834

10.

Gallagher, J.C, Fowler S.E, Detter J.R dan Sherman S.S. 2001. Combination Treatment with Estrogen and Calcitrol in The Prevention of Age-Related Bone Loss. J Clin Endocrinol Metab; 86 : 3618-28

11.

Jasienka et al. CYP17 Genotypes Differ in Salivary 17-b Estradiol Levels: A Study Based on Hormonal Profiles from Entire Menstrual Cycles. Cancer Epidemiol Biomarkers.2006; 10 (11): 2132-2135

12.

Abernethy K, Hillard A, McFall P, et al. Menopause: lifEstyle and therapeutic approaches. Royal College of Nursing, 21

13.

Sutanto L dan Sutando D.B. Menopause wanita dan Gizi, FK UI, Jakarta 2005

14.

Shimp, LA dan Smith, M.A. Twenty Common Problems in Womans Health Care International Edision 2000. Singapore : McGrown-Hill Book Co

15.

Johnston JM, Colvin A, Johnson BD, et al. Comparison of SWAN and WISE Menopausal Status Classification Algorithms. Journal of Women‟s Health. Volume 15, Number 10, 2006

(3)

16.

Lock M, Kaufert P. MEnopAuSe, Local Biologies, and Cultures of Aging. American Journal of Human Biology. Vol 13:494-504, 2001

17.

Palmer JR, Rosenberg L, Wise LA, et al. Onset of Natural Menopause in African American Women. American Journal of Public Health. February 2013, vol 93 No.2.

18.

Anonym. Overview of Menopause. Chapter 1. Available from:

http://www.menopause.org/docs/2012/cg_a.pdf?sfvrsn=2. Acces August 22,2014

19.

Isabela L. 2011. Tingkat Pengetahuan Wanita Pada Masa Klimakterium Tentang Menopause Di Kelurahan Simpang Selayang

Medan. Available

from:http://repository.usu.ac.id/handle/123456789/22413

20.

Ballard KD, Kuh DJ, Wadsworth MEJ. The Role of the Menopause in Women‟s Experiences of the „Change of Life‟. Sociology of Health and Illness Vol. 23 No.4. 2001, p397-424.

21.

Iswayuni N. 2011. Pemberian Ekstrak Plasenta Meningkatkan Kadar Estradiol dan FSH Serta Mengurangi Gejala Menopause. Available from: http://www.pps.unud.ac.id/thesis/pdf_thesis/unud-234-1769780408-babii.pdf. diakses tanggal 22 Agustus,2014

22.

Baziad A. Menopause. Endokrinologi Ginekologi edisi ketiga. Jakarta. Media Aesculapius. 2008;60-61

23.

Kawiyana, I.K.S., 2009, Osteoporosis-Patogenesis, Diagnosis, dan Penanganan Terkini. J Peny Dalam.10;2: 157-69.

(4)

24.

Manolagas SC, Jilka RL., 1995, Bone marrow cytokines and bone remodeling emerging insights into the pathophysiology of osteoporosis. N Eng J Med ;332(5):305-10

25.

Ross PD. Osteoporosis frequency, consequences and risk factor: Arch. Internal Med; 1996; 156(13):1399-14

26.

Rahman IA. Osteoporosis Primer. In : Suherman SK dan Tobing SDAL (Eds). Osteoporosis, edisi 1. CV Infomedika,2006:1-16.

27.

Percival, M. Bone health and osteoporosis. Advanced Nutrition Publications. 1999; Vol.5 no.4:1-6

28.

Nackhbandi, I., Van Ser Merwe, S.W., 2009. Current understanding of osteoporosis associated with liver disease. Gastroenterology and Hepatology, vol 6:660-70

29.

Ormarsdottir, S.2001. Osteoporosis in Chronic Liver Disease. Tryck and Medier, Uppsala University, 7-47

30.

Rouillard, S and Lane, N.E. 2001. Hepatic osteodistrophy. American Association for study of liver disease. 301-7

31.

Setiyohadi, B., 2006. Osteoporosis dalam Sudoyo. A.W., Setyohadi, B., Alwi, I., Simadibrata, M., Setiati, S, (eds) Buku Ajar Ilmu Penyakit Dalam. Edisi IV. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI. Jakarta; 1269-83

32.

Kawiyana, I.K.S., 2009, Crosslink Telopeptida C-Terminal (CTx) sebagai petanda aktivitas Sel Osteoklas pada Osteoporosis Paska Menopause Defisiensi Estrogen. J Peny Dalam.10;2: 79-84.

(5)

33.

Tesar, R., Caudill, J., Colquhon, A., Krueger, D., 2008. Bone densitometry curse. The international society for clinical densitometry. Version 8.

34.

Lindsay, R. Pathogenesis of Postmenopausal osteoporosis, Bailirre Clinical Rhemathology.1993; Vol. 7, Issue 3: 499-513

35.

Turner, L., Freemen, J. Osteoporosis: It’s more than calcium. Journal of health Promotich. 2004; Vol. 2, Issue 3:12-29

36.

Uretmena, S., Golb, M., Cimriuc and Irmakd, E. Effect of chronic liver disease on BMD and bone metabolism markers in postmenopause woman, European Journal of Obstetrics and gynecology and reproductive biology.2005; Vol. 122, Issue1:67-71

37.

Emma S. W., 2000, Tetap Bugar di Usia Lanjut. Trubus Agriwidya.

38.

Suzuki T. 2001. Risk Faktor for Osteoporosis in Asia. J Bone Miner metab.19: 133-141.

39.

Butros Dde A N Nj, Nahas EA, Cangusu LM, Barral AB, Kawakami MS, Risk Factors for Osteoporosis in postmenopousal women from southeast brazillian. 2011. Juni; 33(6): 295-302

40.

Johnell. Advances in osteoporosis: better identification of risk factors can reduce morbidity and mortality: J Internal Med 1996. 239(4): 299-304

41.

Compston, J.E. 1986. Hepatic osteodistrophy: vitamin D metabolism in patients with liver disease. Gut vol 27:1073-90

(6)

osteoprotegerin in postmenopause women. Journal of clinical endocrinology and metabolism. 2009; Vol. 94 No. 12:4844-50

43.

Johnell. Advances in osteoporosis: better identification of risk factors can reduce morbidity and mortality: J Internal Med 1996. 239(4): 299-304

44.

Mac Donald HM NS, Golden MH, Campbell MK, Reid DM, Nutritional associations with bone loss during the menopousal transitition : evidence of a beneficial effect of calcium, alcohol, and fruit, and vegetable nutrients and of a detrimental effect of fatty acids 2004:155-65

45.

Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Den Res 85,2006:584-595.

46.

Rizzoli R. Pathophysiology of bone loss. 17th IOF Advanced Training Course on Osteoporosis. Lyon, France, January 29-31, 2008.

47.

Heinemann L,Potthoff.P, Schneider.H. International versus of The Menopause Rating Scale: A Methodological review. Health and Quality of Life Outcome 2003; 1:28

48.

Kaunitz AM. Oral contraceptive use in menopause. Am J Obstet Gynecol 2001; 185: S32-7, Klein NA, Soules MR. Endocrine changes of the menopause. Clin Obstet Gynecol 2004;41:912-20

49.

Aprilia, Dina Ariestine. 2010. Terapi Suluh Hormon Pada Osteoporosis. Universitas Sumatera Utara

(7)

50.

Goodman N, Cobin R, Ginzburg S, Katz I, Woode D, 2011. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause. AACE Guidelines, 2-17, Sherwood, L. 2001. Human Physiology: From cells to System). 2th. ed. Division of International Thomson Publishing Inc. 725-728.

51.

Wardhana, Wisnu. 2012. Faktor – Faktor Risiko Osteoporosis Pada Pasien Dengan Usia Di Atas 50 Tahun. Universitas Diponegoro

52.

Bambang Setiyohadi. 2001. Osteoporosis dan Penatalaksanaanya. Naskah yang dibacakan pada pertemuan Osteoporosis pada Lansia.Denpasar 24 Agustus.

53.

Seeman E. 2003. Physiology of Aging. Invite review : Pathogenesis of Osteoporosis. J Appl Physiol : 95; 2124-51.

54.

Jordan K. M dan Cooper C. 2008. Epidemiology od Osteoporosis. Best Practice and Reasearch Clinical Rheumatology; 16(5) : 795-806.

55.

Malavolta, N Zanardi M, Veronesi M, Ripamonti C dan Gnudi S. 1999. Calcitrol and Alendronate Combination Treatment in Menopausal Women with Low Bone Mass. Int.J. Tissue React; 20(12): 51-9.

56.

Tamura T, et al. 1993. Soluble Interleukin-^ Receptor Triggers Osteoklast Formation by Interleukin ^. Proc. Natl. Acad. Sci; 90; 11924-8.